290
T. Mino et al. / Tetrahedron: Asymmetry 12 (2001) 287–291
4.5. Preparation of (S)-N-(1-benzyl-2-methoxyethyl)-2-
(diphenylphosphino)naphthalenecarboxamide 6
4.3. Preparation of (S)-N-(1-benzyl-2-methoxyethyl)-2-
hydroxynaphthalenecarboxamide 7
To a solution of NiCl2dppe (0.015 mmol, 0.008 g) in
DMF (0.3 mL) was added diphenylphosphine (0.4
mmol, 0.07 mL) at room temperature, and then the
resulting solution was heated at 100°C. After heating
at 100°C for 30 min, a solution of amide 8 (0.3 mmol,
0.140 g) and DABCO (0.34 mmol, 0.040 g) in DMF
(0.7 mL) was added at once, the resulting solution was
kept at 100°C for 24 h, and then the solution was
cooled to room temperature. The solution was diluted
with ethyl acetate and then washed with water and
brine. The organic phase was dried over Na2SO4, con-
centrated under reduced pressure and the residue was
purified by silica gel column chromatography to give 6
in 84% (0.25 mmol, 0.126 g) yield; mp 57.0–58.0°C.
[h]2D5 −18.7 (c 0.17, CHCl3). 1H NMR (300 MHz,
CDCl3): l 2.76–2.92 (m, 1H), 2.99–3.10 (m, 1H), 3.15
(s, 3H), 3.31–3.33 (m, 2H), 4.66–4.78 (m, 1H), 6.07 (d,
J=8.8 Hz, 1H), 7.10–7.17 (m, 1H), 7.19–7.38 (m,
15H), 7.38–7.44 (m, 1H), 7.45–7.54 (m, 1H), 7.55–7.67
(m, 1H), 7.68–7.74 (m, 1H), 7.75–7.82 (m, 1H). 31P
NMR (CDCl3): l −12.75. 13C NMR (CDCl3): l 37.32,
50.68, 58.77, 72.06, 125.75–142.85 (m, Ar-C), 168.40
(d, J=5.0 Hz). IR (KBr): 3409, 3293, 3054, 2923,
1656, 1496, 1251, 1182, 1120, 1026, 908, 817, 744, 698,
514 cm−1. FABMS (m/z): 504 (M+1). HRMS (FAB)
calcd for C33H31NO2P (M+H): 504.2092; found:
504.2072.
To a mixture of (S)-(+)-2-amino-1-methoxy-3-phenyl-
propane hydrochloride (2.0 mmol, 0.403 g) in benzene
(5 mL) was added a trimethylaluminium in hexane
(2.06 mmol, 2.1 mL, 0.98 M) at room temperature
under an argon atmosphere. The mixture was stirred
under reflux for 3 h and a benzene (3 mL) solution of
methyl 2-hydroxy-1-naphthoate (1.0 mmol, 0.202 g)
was added to the mixture. After 4 h, the reaction
mixture was cooled to room temperature. The mixture
was diluted with ethyl acetate and water. The organic
phase was washed with brine and dried over Na2SO4.
The filtrate was concentrated under reduced pressure
to give the residue, which was then purified by silica
gel column chromatography. Compound
7
was
afforded in 60% (0.60 mmol, 0.200 g) yield; mp 122.2–
123.0°C. [h]2D5 −54.4 (c 0.16, CHCl3). 1H NMR (300
MHz, CDCl3): l 3.00–3.12 (m, 2H), 3.40 (s, 3H), 3.48
(dd, J=3.5 and 9.5 Hz, 1H), 3.83 (dd, J=3.9 and 9.5
Hz, 1H), 4.62–4.67 (m, 1H), 6.64 (d, J=8.3 Hz, 1H),
7.15 (d, J=8.9 Hz, 1H), 7.23–7.40 (m, 6H), 7.41–7.46
(m, 1H), 7.75–7.81 (m, 2H), 7.87 (d, J=8.5 Hz, 1H),
11.31 (s, 1H). 13C NMR (CDCl3): l 37.40, 51.12,
59.10, 72.26, 109.82, 119.30, 122.54, 123.34, 126.77,
128.04, 128.69, 129.32, 129.37, 130.66, 133.78, 137.72,
159.29, 169.45. IR (KBr): 3261, 3178, 3068, 2950,
1637, 1540, 1513, 1436, 1344, 1292, 1263, 1207, 1105,
1072, 958, 829, 732, 698 cm−1. FABMS (m/z): 335
(M+1). HRMS (FAB) calcd for C21H22NO3 (M+H):
336.1600; found: 336.1583.
4.6. General procedure for asymmetric allylic
alkylations
To a mixture of [Pd(h3-C3H5)Cl]2 (0.01 mmol, 0.004
g), chiral amide (0.02 mmol), and lithium acetate (0.01
mmol, 0.001 g) in ether (1 mL) was added BSA (1.5
mmol, 0.37 mL), racemic 1,3-diphenyl-2-propenyl ace-
tate 9a (0.5 mmol, 0.126 g), and dimethyl malonate
10a (1.5 mmol, 0.17 mL) at room temperature under
an argon atmosphere. After stirring for 24 h, the reac-
tion mixture was diluted with ether and water. The
organic layer was washed with brine and dried over
MgSO4. The filtrate was concentrated under reduced
pressure to give the residue, which was purified by
column chromatography to give 11a (Table 1, entry 5)
4.4. Preparation of (S)-N-(1-benzyl-2-methoxyethyl)-2-
(trifluoromethanesulfonyloxy)naphthalenecarboxamide 8
To a mixture of amide 7 (0.5 mmol, 0.167 g), pyridine
(1.2 mmol, 0.1 mL) and benzene (1 mL) was added
trifluoromethanesulfonic anhydride (0.83 mmol, 0.14
mL) at 0°C, and the mixture was stirred at room
temperature for 6 h. After removal of the solvent, the
residue was diluted with ethyl acetate and then washed
with 5% aq. HCl, satd NaHCO3, and brine. The
organic phase was dried over MgSO4 and concentrated
under reduced pressure. The residue was purified by
silica gel column chromatography to give 8 in 95%
(0.476 mmol, 0.222 g) yield; mp 127.0–127.7°C. [h]D25
1
in 95% yield; 84% e.e.; [h]2D0=+16.0 (c 1.0, EtOH); H
NMR (400 MHz, CDCl3): l 3.51 (s, 3H), 3.70 (s, 3H),
3.95 (d, J=11.0 Hz, 1H), 4.27 (dd, J=8.5 and 11.0
Hz, 1H), 6.44 (dd, J=8.5 and 15.8 Hz, 1H), 6.71 (d,
J=15.8 Hz, 1H), 7.19–7.33 (m, 10H); 13C NMR (100
MHz, CDCl3): l 49.20, 52.45, 52.63, 57.66, 126.40,
127.18, 127.58, 127.86, 128.48, 128.73, 129.12, 131.85,
136.83, 140.18, 167.79, 168.21; EIMS (m/z): 324 (M+,
30). 11b (Table 3, entry 4): 95% yield; 53% e.e.; [h]2D0=
1
−23.7 (c 0.35, CHCl3). H NMR (300 MHz, CDCl3): l
2.99–3.14 (m, 2H), 3.38 (s, 3H), 3.45–3.50 (m, 1H),
3.55 (dd, J=3.8 and 9.4 Hz, 1H), 4.68–4.78 (m, 1H),
6.43 (d, J=8.7 Hz, 1H), 7.25–7.40 (m, 6H), 7.47–7.55
(m, 3H), 7.84–7.88 (m, 1H), 7.93 (d, J=9.1 Hz, 1H).
13C NMR (CDCl3): l 37.55, 51.10, 58.94, 72.14,
118.58 (q, J=4.2 Hz), 118.86, 125.70, 126.62, 127.50,
128.06, 128.25, 128.44, 128.65, 129.53, 130.68, 131.63,
132.32, 137.89, 142.64, 163.36. IR (KBr): 3309, 3062,
2925, 1648, 1544, 1423, 1220, 1139, 954, 835, 813, 732,
617 cm−1. FABMS (m/z): 468 (M+1). HRMS (FAB)
calcd for C22H21F3NO5S (M+H): 468.1093; found:
468.1107.
1
+10.6 (c 1.0, EtOH); H NMR (400 MHz, CDCl3): l
1.13–1.28 (m, 6H), 1.47 (s, 3H), 4.04–4.18 (m, 2H),
4.14–4.20 (m, 2H), 4.29 (d, 8.9 Hz, 1H), 6.44 (d, 15.8
Hz, 1H), 6.71 (dd, 8.9 and 15.8 Hz, 1H), 7.18–7.34 (m,
10H); 13C NMR (100 MHz, CDCl3): l 13.94, 14.03,
18.81, 46.19, 53.72, 58.89, 61.34, 126.33, 127.10,
127.31, 128.20, 128.43, 128.86, 129.61, 132.58, 170.92,
171.19; EIMS (m/z): 366 (M+, 3).